Abdel-Razek Abdel-Rahman A, Abdel-Salam Amina, El-Sonbaty Marwa M, Youness Eman R
aDepartment of Pediatrics, New Children's Hospital, Cairo University Departments of bChild Health cMedical Biochemistry, National Research Center, Cairo, Egypt.
J Egypt Public Health Assoc. 2013 Dec;88(3):148-52. doi: 10.1097/01.EPX.0000436490.10201.28.
Thyroid dysfunction is a known complication of transfusion-dependent β-thalassemia. However, information on its frequency and risk factors among Egyptian Children is still unclear.
We aimed to determine the frequency of functional thyroid abnormalities among young patients with β-thalassemia and compare the thyroid function status among patients with β-thalassemia major (TM) and β-thalassemia intermedia (TI).
This was a cross-sectional study that included 52 β-thalassemia children [27 boys and 25 girls; 34 (65.4%) with TM and 18 (34.6%) with TI]. Their mean age was 16.0±1.91 (range: 12-18) years. Thyroid function and iron load status were assessed by measurement of free tetraiodothyronine, free triiodothyronine, thyroid stimulating hormone (TSH), and serum ferritin concentrations.
Serum TSH of the studied cases ranged from 0.28 to 25 μIU/ml with a mean of 4.5±4.8 μIU/ml. None of the studied cases had overt primary hypothyroidism and the frequency of subclinical hypothyroidism was 19.2%. No risk factors for thyroid dysfunction could be identified among our cases. The thyroid profile was comparable in TM and TI patients (P>0.05) and the frequency of subclinical hypothyroidism among TM cases was 20.6% and it was comparable to the 16.7% found among TI patients (P>0.05). No correlations were found between TSH, serum ferritin, chelation therapy, and frequency of blood transfusion.
Both TM and TI patients are at risk for subclinical thyroid failure regardless of their iron overload status. Early evaluation of thyroid function in β-thalassemia children and thyroid replacement therapy for subclinical hypothyroidism should be introduced in the treatment protocols.
甲状腺功能障碍是依赖输血的β地中海贫血的一种已知并发症。然而,关于埃及儿童中其发生率及危险因素的信息仍不明确。
我们旨在确定β地中海贫血年轻患者中功能性甲状腺异常的发生率,并比较重型β地中海贫血(TM)和中间型β地中海贫血(TI)患者的甲状腺功能状态。
这是一项横断面研究,纳入了52例β地中海贫血儿童[27例男孩和25例女孩;34例(65.4%)为TM,18例(34.6%)为TI]。他们的平均年龄为16.0±1.91岁(范围:12 - 18岁)。通过测量游离甲状腺素、游离三碘甲状腺原氨酸、促甲状腺激素(TSH)和血清铁蛋白浓度来评估甲状腺功能和铁负荷状态。
研究病例的血清TSH范围为0.28至25 μIU/ml,平均为4.5±4.8 μIU/ml。研究病例中无一例有明显的原发性甲状腺功能减退,亚临床甲状腺功能减退的发生率为19.2%。在我们的病例中未发现甲状腺功能障碍的危险因素。TM和TI患者的甲状腺指标具有可比性(P>0.05),TM病例中亚临床甲状腺功能减退的发生率为20.6%,与TI患者中发现的16.7%具有可比性(P>0.05)。未发现TSH、血清铁蛋白、螯合疗法和输血频率之间存在相关性。
无论铁过载状态如何,TM和TI患者均有亚临床甲状腺功能减退的风险。应在治疗方案中引入对β地中海贫血儿童甲状腺功能的早期评估以及对亚临床甲状腺功能减退的甲状腺替代治疗。